IPO Boutique

Zai Lab Limited IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Zai Lab Limited, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Zai Lab LimitedZLAB -
NASDAQ
$16.00-$18.00 $18.00 $24.258.0 million ADSs9/20/2017
J.P. Morgan, Citigroup, Leerink Partners
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-08-15
Terms Added 2017-09-01



Zai Lab Limited Quote & Chart - Click for current quote - ZLAB

About Zai Lab Limited (adapted from Zai Lab Limited prospectus):
They are an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the areas of oncology, autoimmune and infectious diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ZLAB " IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved